| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 91
Authors: 315,
Journals: 56,
Outer References: 3533
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 47 | 1 2002 ANNALS OF NEUROLOGY 52(6):722-731 Kawamoto Y; Akiguchi I; Nakamura S; Budka H Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy | 2 | 6 |
| 2 | 1 | 1 | 2 2002 CHEMICAL & ENGINEERING NEWS 80(23):34-34 [Anon] Explanation for Parkinson's degeneration | 0 | 0 |
| 3 | 1 | 179 | 3 2002 HUMAN MOLECULAR GENETICS 11(20):2395-2407 Lotharius J; Brundin P Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease | 8 | 13 |
| 4 | 1 | 42 | 4 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(52):50980-50984 da Costa CA; Paitel E; Vincent B; Checler F alpha-Synuclein lowers p53-dependent apoptotic response of neuronal cells - Abolishment by 6-hydroxydopamine and implication for Parkinson's disease | 5 | 11 |
| 5 | 1 | 41 | 5 2002 MOLECULAR BRAIN RESEARCH 108(1-2):33-39 Ubl A; Berg D; Holzmann C; Kruger R; Berger K; Arzberger T; Bornemann A; Riess O 14-3-3 protein is a component of Lewy bodies in Parkinson's disease - Mutation analysis and association studies of 14-3-3 eta | 3 | 1 |
| 6 | 1 | 12 | 6 2002 NATURE MEDICINE 8(6):564-565 Welch K; Yuan JY Releasing the nerve cell killers | 4 | 4 |
| 7 | 0 | 30 | 7 2002 NATURE MEDICINE 8(6):600-606 Xu J; Kao SY; Lee FJS; Song WH; Jin LW; Yankner BA Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease | 90 | 90 |
| 8 | 2 | 35 | 8 2002 NATURE NEUROSCIENCE 5:1058-1061 Dawson TM; Dawson VL Neuroprotective and neurorestorative strategies for Parkinson's disease | 1 | 14 |
| 9 | 2 | 137 | 9 2002 NATURE REVIEWS NEUROSCIENCE 3(12):932-942 Lotharius J; Brundin P Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein | 13 | 40 |
| 10 | 1 | 20 | 10 2002 NEURON 35(2):219-222 Dawson TM; Mandir AS; Lee MK Animal models of PD: Pieces of the same puzzle? | 9 | 21 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 53 | 11 2002 NEURON 36(6):1007-1019 Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons | 19 | 73 |
| 12 | 1 | 38 | 12 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(22):13972-13974 Steece-Collier K; Maries E; Kordower JH Etiology of Parkinson's disease: Genetics and environment revisited | 0 | 8 |
| 13 | 1 | 94 | 13 2003 ANNALS OF NEUROLOGY 53:S73-S84 McNaught KS; Olanow CW Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease | 0 | 23 |
| 14 | 2 | 5 | 14 2003 ANNALS OF NEUROLOGY 54(1):135-135 Berg D; Riess O; Bornemann A Specification of 14-3-3 proteins in Lewy bodies | 1 | 1 |
| 15 | 2 | 199 | 15 2003 ANNUAL REVIEW OF NEUROSCIENCE 26:267-298 Caughey B; Lansbury PT Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders | 2 | 31 |
| 16 | 1 | 138 | 16 2003 ANTIOXIDANTS & REDOX SIGNALING 5(3):337-348 Lee SJ alpha-synuclein aggregation: A link between mitochondrial defects and Parkinson's disease? | 1 | 4 |
| 17 | 2 | 29 | 17 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 309(3):679-684 Oluwatosin-Chigbu Y; Robbins A; Scott CW; Arriza JL; Reid JD; Zysk JR Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells | 0 | 3 |
| 18 | 5 | 118 | 18 2003 BIOCHEMISTRY 42(26):7871-7878 Volles MJ; Lansbury PT Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease | 4 | 22 |
| 19 | 1 | 120 | 19 2003 BRAIN PATHOLOGY 13(4):630-638 Lee HG; Petersen RB; Zhu XW; Honda K; Aliev G; Smith MA; Perry G Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? | 0 | 0 |
| 20 | 1 | 42 | 20 2003 BRAIN RESEARCH 989(2):205-213 Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS 3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 145 | 21 2003 CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 30:S10-S18 Huang ZA; de la Fuente-Fernandez R; Stoessl AJ Etiology of Parkinson's disease | 0 | 2 |
| 22 | 2 | 33 | 22 2003 CELL 113(4):457-468 Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EMC; Orr HT; Botas J; Zoghbi HY Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1 | 6 | 36 |
| 23 | 3 | 37 | 23 2003 CELL 114(1):1-8 Giasson BI; Lee VMY Are ubiquitination pathways central to Parkinson's disease? | 3 | 19 |
| 24 | 3 | 17 | 24 2003 CURRENT BIOLOGY 12(13):R522-R524 Cookson MR Neurodegeneration: How does Parkin prevent Parkinson's disease? | 0 | 0 |
| 25 | 2 | 33 | 25 2003 DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 16(1):46-51 Tabet N; Walker Z; Mantel D; Costa D; Orrell M In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls - A preliminary report | 0 | 0 |
| 26 | 4 | 72 | 26 2003 FASEB JOURNAL 17(12) Wersinger C; Prou D; Vernier P; Sidhu A Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress | 0 | 0 |
| 27 | 3 | 42 | 27 2003 HUMAN MOLECULAR GENETICS 12(19):2457-2466 Scherzer CR; Jensen RV; Gullans SR; Feany MB Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease | 1 | 5 |
| 28 | 3 | 40 | 28 2003 HUMAN MOLECULAR GENETICS 12(21):2807-2816 Macedo MG; Anar B; Bronner IF; Cannella M; Squitieri F; Bonifati V; Hoogeveen A; Heutink P; Rizzu P The DJ-1(L166P) mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes | 1 | 13 |
| 29 | 1 | 137 | 29 2003 INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 228 228:1-30 Sugaya K Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases | 0 | 0 |
| 30 | 4 | 44 | 30 2003 IUBMB LIFE 55(6):315-322 Lim KL; Lim TM Molecular mechanisms of neurodegeneration in Parkinson's disease: Clues from Mendelian syndromes | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 1 | 45 | 31 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(26):24095-24102 Ihara M; Tomimoto H; Kitayama H; Morioka Y; Akiguchi I; Shibasaki H; Noda M; Kinoshita M Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies | 0 | 7 |
| 32 | 2 | 67 | 32 2003 JOURNAL OF CLINICAL INVESTIGATION 111(2):145-151 Dawson TM; Dawson VL Rare genetic mutations shed light on the pathogenesis of Parkinson disease | 6 | 34 |
| 33 | 1 | 76 | 33 2003 JOURNAL OF CLINICAL INVESTIGATION 111(2):163-169 Ischiropoulos H; Beckman JS Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? | 1 | 29 |
| 34 | 2 | 58 | 34 2003 JOURNAL OF NEUROCHEMISTRY 85(4):957-968 Baptista MJ; O'Farrell C; Daya S; Ahmad R; Miller DW; Hardy J; Farrer MJ; Cookson MR Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines | 3 | 5 |
| 35 | 1 | 53 | 35 2003 JOURNAL OF NEUROCHEMISTRY 85(6):1468-1479 Hashimoto M; Takenouchi T; Rockenstein E; Masliah E alpha-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease | 3 | 7 |
| 36 | 1 | 56 | 36 2003 JOURNAL OF NEUROCHEMISTRY 86(1):165-172 Lakso M; Vartiainen S; Moilanen AM; Sirvio J; Thomas JH; Nass R; Blakely RD; Wong G Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein | 3 | 6 |
| 37 | 1 | 83 | 37 2003 JOURNAL OF NEUROLOGY 250:2-10 Hattori N; Kobayashi H; Sasaki-Hatano Y; Sato K; Mizuno Y Familial Parkinson's disease: a hint to elucidate the mechanisms of nigral degeneration | 0 | 1 |
| 38 | 1 | 68 | 38 2003 JOURNAL OF NEUROSCIENCE 23(7):2564-2571 Mash DC; Ouyang Q; Pablo J; Basile M; Izenwasser S; Lieberman A; Perrin RJ Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons | 0 | 2 |
| 39 | 1 | 54 | 39 2003 JOURNAL OF NEUROSCIENCE 23(7):2744-2750 Avshalumov MV; Chen BT; Marshall SP; Pena DM; Rice ME Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2 | 0 | 6 |
| 40 | 1 | 43 | 40 2003 JOURNAL OF NEUROSCIENCE RESEARCH 74(2):278-285 Yang LC; Sugama S; Chirichigno JW; Gregorio J; Lorenzl S; Shin DH; Browne SE; Shimizu Y; Joh TH; Beal MF; Albers DS Minocycline enhances MPTP toxicity to dopaminergic neurons | 0 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 3 | 102 | 41 2003 LANCET NEUROLOGY 2(4):221-228 Hardy J; Cookson MR; Singleton A Genes and parkinsonism | 2 | 16 |
| 42 | 2 | 18 | 42 2003 M S-MEDECINE SCIENCES 19(5):613-619 Corti O; Brice A Parkinson's disease: what do the genes involved in familial forms tell us? | 0 | 0 |
| 43 | 1 | 12 | 43 2003 MOLECULAR PSYCHIATRY 8(4):369-370 Chesselet MF Dopamine and Parkinson's disease: is the killer in the house? | 1 | 1 |
| 44 | 2 | 87 | 44 2003 MOVEMENT DISORDERS 18(7):729-737 Orth M; Tabrizi SJ Models of Parkinson's disease | 1 | 3 |
| 45 | 3 | 13 | 45 2003 NATURE MEDICINE 9(7):825-826 Paulson H Polyglutamine neurodegeneration: minding your Ps and Qs | 0 | 2 |
| 46 | 3 | 93 | 46 2003 NATURE REVIEWS NEUROSCIENCE 4(9):727-738 Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K The role of alpha-synuclein in Parkinson's disease: Insights from animal models | 1 | 8 |
| 47 | 4 | 157 | 47 2003 NATURE REVIEWS NEUROSCIENCE 4(9):752-762 Berg D; Holzmann C; Riess O 14-3-3 proteins in the nervous system | 1 | 7 |
| 48 | 3 | 156 | 48 2003 NEUROCHEMICAL RESEARCH 28(11):1743-1756 Hashimoto M; Masliah E Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies | 0 | 1 |
| 49 | 1 | 63 | 49 2003 NEUROCHEMISTRY INTERNATIONAL 43(1):1-7 Shastry BS Neurodegenerative disorders of protein aggregation | 1 | 6 |
| 50 | 4 | 98 | 50 2003 NEUROMOLECULAR MEDICINE 4(1-2):95-108 Moore DJ; Dawson VL; Dawson TM Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 3 | 26 | 51 2003 NEURON 37(1):7-10 Cookson MR Pathways to parkinsonism | 6 | 24 |
| 52 | 1 | 37 | 52 2003 NEURON 37(4):583-595 Sharon R; Bar-Joseph I; Frosch MP; Walsh DM; Hamilton JA; Selkoe DJ The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease | 8 | 26 |
| 53 | 2 | 235 | 53 2003 NEURON 39(6):889-909 Dauer W; Przedborski S Parkinson's disease: Mechanisms and models | 1 | 21 |
| 54 | 7 | 163 | 54 2003 NEURON 40(2):427-446 Ciechanover A; Brundin P The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg | 0 | 18 |
| 55 | 7 | 25 | 55 2003 NEURON 40(3):453-456 Eriksen JL; Dawson TM; Dickson DW; Petrucelli L Caught in the act: alpha-synuclein is the culprit in Parkinson's disease | 0 | 2 |
| 56 | 8 | 402 | 56 2003 NEUROPHARMACOLOGY 45(1):14-44 Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease | 3 | 10 |
| 57 | 1 | 25 | 57 2003 NEUROREPORT 14(4):551-554 Suzuki K; Iseki E; Katsuse O; Yamaguchi A; Katsuyama K; Aoki I; Yamanaka S; Kosaka K Neuronal accumulation of alpha-and beta-synucleins in the brain of a GM(2) gangliosidosis mouse model | 0 | 4 |
| 58 | 1 | 18 | 58 2003 NEUROSCIENCE LETTERS 337(1):5-8 Kelada SN; Stapleton PL; Farin FM; Bammler TK; Eaton DL; Smith-Weller T; Franklin GM; Swanson PD; Longstreth WT; Checkoway H Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease | 0 | 1 |
| 59 | 1 | 1 | 59 2003 NEUROSCIENTIST 9(3):169-169 [Anon] Dopamine-dependent alpha-synuclein neurotoxicity | 0 | 0 |
| 60 | 2 | 51 | 60 2003 NEUROSIGNALS 12(6):315-324 Kheradpezhouh M; Shavali S; Ebadi M Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 1 | 114 | 61 2003 NEUROTOXICITY RESEARCH 5(3):165-176 Asanuma M; Miyazaki I; Ogawa N Dopamine-or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease | 0 | 8 |
| 62 | 3 | 59 | 62 2003 PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON 991:80-92 Lim KL; Dawson VL; Dawson TM The cast of molecular characters in Parkinson's disease - Felons, conspirators, and suspects | 0 | 1 |
| 63 | 1 | 53 | 63 2003 PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON 991:93-100 Ischiropoulos H Oxidative modifications of alpha-synuclein | 1 | 3 |
| 64 | 2 | 40 | 64 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(5):2884-2889 Kirik D; Annett LE; Burger C; Muzyczka N; Mandel RJ; Bjorklund A Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: A new primate model of Parkinson's disease | 5 | 11 |
| 65 | 4 | 24 | 65 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(16):9111-9113 Cookson MR Crystallizing ideas about Parkinson's disease | 0 | 2 |
| 66 | 4 | 56 | 66 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(21):12438-12443 Dong ZZ; Ferger B; Paterna JC; Vogel D; Furler S; Osinde M; Feldon J; Bueler H Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1 | 0 | 4 |
| 67 | 1 | 64 | 67 2003 TRENDS IN MOLECULAR MEDICINE 9(3):126-132 Barzilai A; Melamed E Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease | 0 | 3 |
| 68 | 1 | 25 | 68 2003 TRENDS IN NEUROSCIENCES 26(8):407-410 Forman MS; Lee VMY; Trojanowski JQ 'Unfolding' pathways in neurodegenerative disease | 1 | 8 |
| 69 | 2 | 20 | 69 2003 TRENDS IN NEUROSCIENCES 26(10):517-519 Welch K; Yuan JY alpha-synuclein oligomerization: a role for lipids? | 2 | 3 |
| 70 | 3 | 70 | 70 2004 AMERICAN JOURNAL OF PATHOLOGY 165(2):577-592 Satoh J; Yamamura T; Arima K The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 3 | 63 | 71 2004 BIOCHEMISTRY 43(5):1242-1253 Wersinger C; Vernier P; Sidhu A Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant | 0 | 0 |
| 72 | 2 | 76 | 72 2004 BIOCHEMISTRY 43(18):5539-5550 Moussa CEH; Wersinger C; Tomita Y; Sidhu A Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine | 0 | 0 |
| 73 | 7 | 278 | 73 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(14):1729-1750 Bonifati V; Oostra BA; Heutink P Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms | 0 | 0 |
| 74 | 3 | 54 | 74 2004 CURRENT OPINION IN PHARMACOLOGY 4(1):79-84 Le W; Appel SH Mutant genes responsible for Parkinson's disease | 0 | 0 |
| 75 | 5 | 112 | 75 2004 FASEB JOURNAL 18(6):617-626 Recchia A; Debetto P; Negro A; Guidolin D; Skaper SD; Giusti P alpha-synuclein and Parkinson's Disease | 0 | 0 |
| 76 | 4 | 145 | 76 2004 FASEB JOURNAL 18(6):637-647 Sidhu A; Wersinger C; Vernier P Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? | 0 | 0 |
| 77 | 1 | 48 | 77 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(15):15240-15247 Kalivendi SV; Cunningham S; Kotamraju S; Joseph J; Hillard CJ; Kalyanaraman B alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells - Intermediacy of transferrin receptor iron and hydrogen peroxide | 0 | 0 |
| 78 | 2 | 66 | 78 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(18):18614-18622 Palacino JJ; Sagi D; Goldberg MS; Krauss S; Motz C; Wacker M; Klose J; Shen J Mitochondrial dysfunction and oxidative damage in parkin-deficient mice | 1 | 3 |
| 79 | 5 | 137 | 79 2004 JOURNAL OF CELL SCIENCE 117(10):1875-1884 Dougherty MK; Morrison DK Unlocking the code of 14-3-3 | 0 | 0 |
| 80 | 2 | 47 | 80 2004 JOURNAL OF COMPARATIVE NEUROLOGY 473(1):97-106 Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: Human midbrain dopamine neurons | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 1 | 66 | 81 2004 JOURNAL OF NEURAL TRANSMISSION 111(8):1017-1030 Blandini F; Cosentino M; Mangiagalli A; Marino F; Samuele A; Rasini E; Fancellu R; Tassorelli C; Pacchetti C; Martignoni E; Riboldazzi G; Calandrella D; Lecchini S; Frigo G; Nappi G Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment | 0 | 0 |
| 82 | 11 | 91 | 82 2004 JOURNAL OF NEUROCHEMISTRY 89(5):1126-1136 Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice | 0 | 0 |
| 83 | 4 | 79 | 83 2004 JOURNAL OF NEUROCHEMISTRY 89(6):1318-1324 Perez RG; Hastings TG Could a loss of alpha-synuclein function put dopaminergic neurons at risk? | 0 | 0 |
| 84 | 1 | 25 | 84 2004 NATURE 429(6994):883-891 Lu T; Pan Y; Kao SY; Li C; Kohane I; Chan J; Yankner BA Gene regulation and DNA damage in the ageing human brain | 0 | 1 |
| 85 | 4 | 137 | 85 2004 NATURE REVIEWS DRUG DISCOVERY 3(3):205-214 Barnham KJ; Masters CL; Bush AI Neurodegenerative diseases and oxidative stress | 0 | 4 |
| 86 | 3 | 105 | 86 2004 NATURE REVIEWS GENETICS 5(2):136-U17 Jakel RJ; Schneider BL; Svendsen CN Using human neural stem cells to model neurological disease | 0 | 1 |
| 87 | 1 | 32 | 87 2004 NEUROLOGIA 19(2):53-58 Campos V; Rebollo AC; Jimenez-Hoyuela JM; Gomez-Doblas JJ; Medialdea PO; Vila E; Gutierrez-Hurtado A Early alterations of adrenergic cardiac function in Parkinson's disease | 0 | 0 |
| 88 | 3 | 80 | 88 2004 NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 30(3):215-224 Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM Protein misfolding in neurodegenerative diseases | 0 | 0 |
| 89 | 2 | 27 | 89 2004 NEUROSCIENCE LETTERS 357(2):143-146 Hernandez F; Cuadros R; Avila J Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers | 0 | 0 |
| 90 | 8 | 61 | 90 2004 NEUROSCIENTIST 10(1):63-72 Baptista MJ; Cookson MR; Miller DW Parkin and alpha-synuclein: Opponent actions in the pathogenesis of Parkinson's disease | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 5 | 139 | 91 2004 PROTEIN AND PEPTIDE LETTERS 11(3):213-228 Walsh DM; Selkoe DJ Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.08.24